Skip to Main Content

Paper Details

The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space.
Nat Med
177
2018
DNA, FFPE samples, Glioblastoma, bisulfite, cancer, epigenome, glioblastoma, glioblastoma tumors, patient, tumor, tumors
Chromosome Mapping, DNA Methylation, Disease Progression, Epigenesis, Genetic, Female, Genetic Heterogeneity, Genome, Human, Glioblastoma, High-Throughput Nucleotide Sequencing, Humans, Male, Neoplasm Recurrence, Local
Author NameAffiliation
Johanna KlughammerCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Barbara KieselMedical University of Vienna
Barbara KieselComprehensive Cancer Center, Medical University of Vienna
Thomas RoetzerComprehensive Cancer Center, Medical University of Vienna
Thomas RoetzerInstitute of Neurology, Medical University of Vienna
Nikolaus FortelnyCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Amelie NemcCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Karl-Heinz NenningMedical University of Vienna
Julia FurtnerComprehensive Cancer Center, Medical University of Vienna
Julia FurtnerMedical University of Vienna
Nathan Sheffield (CM4AI)Center for Public Health Genomics, University of Virginia
Paul DatlingerCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Nadine PeterComprehensive Cancer Center, Medical University of Vienna
Nadine PeterInstitute of Neurology, Medical University of Vienna
Martha NowosielskiMedical University of Innsbruck
Martha NowosielskiUniversity Medical Center, German Cancer Research Center
Marco AugustinCenter for Medical Physics and Biomedical Engineering, Medical University of Vienna
Mario MischkulnigMedical University of Vienna
Mario MischkulnigComprehensive Cancer Center, Medical University of Vienna
Thomas Str??belComprehensive Cancer Center, Medical University of Vienna
Thomas Str??belInstitute of Neurology, Medical University of Vienna
Don??t Alp??rCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Bekir Erg??nerCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Martin SenekowitschCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Patrizia MoserMedical University of Innsbruck
Christian F FreyschlagMedical University of Innsbruck
Johannes KerschbaumerMedical University of Innsbruck
Claudius Thom??Medical University of Innsbruck
Astrid E GramsMedical University of Innsbruck
G??nther StockhammerMedical University of Innsbruck
Melitta KitzwoegererUniversity Hospital of St. Poelten, Karl Landsteiner University of Health Sciences
Stefan OberndorferUniversity Hospital of St. Poelten, Karl Landsteiner University of Health Sciences
Franz MarholdUniversity Hospital of St. Poelten, Karl Landsteiner University of Health Sciences
Serge WeisKepler University Hospital, Johannes Kepler University of Linz
Johannes TrenklerKepler University Hospital, Johannes Kepler University of Linz
Johanna BuchroithnerKepler University Hospital, Johannes Kepler University of Linz
Josef PichlerKepler University Hospital, Johannes Kepler University of Linz
Johannes HaybaeckMedical University of Innsbruck
Johannes HaybaeckDiagnostic & Research Center for Molecular BioMedicine, Institute of Pathology, Medical University of Graz
Johannes HaybaeckOtto-von-Guericke University of Magdeburg
Stefanie KrassnigDiagnostic & Research Center for Molecular BioMedicine, Institute of Pathology, Medical University of Graz
Kariem Mahdy AliMedical University of Graz
Gord von CampeMedical University of Graz
Franz PayerMedical University of Graz
Camillo Sherif
Julius Preiser
Thomas HauserParacelsus Private Medical University
Peter A WinklerParacelsus Private Medical University
Waltraud KleindienstParacelsus Private Medical University
Franz G W??rtzInstitute of Pathology, State Hospital Klagenfurt
  • 1 - 50

Datasets